ACT_831/2025

System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Prozessuale & UnteranträgeKostenfestsetzungenParis CDApplication For Costs—

Übersicht Entscheidungen Dokumente Zeitverlauf

Parteien

Kläger

Roche Diabetes Care GmbH(Roche Group)

Vertreter: Christof Augenstein (Kather Augenstein Rechtsanwälte PartGmbB); Katharina Brandt (Kather Augenstein Rechtsanwälte PartGmbB); Robert Knaps (Kather Augenstein Rechtsanwälte PartGmbB); Thomas Kronberger (Grünecker Patent- und Rechtsanwälte PartGmbB)

Beklagte

Tandem Diabetes Care, Inc.
Tandem Diabetes Care Europe B.V.

Vertreter: Charlotte Garnitsch (Taylor Wessing N.V.); Wim Maas (Taylor Wessing N.V.); Alexander Rubusch (Taylor Wessing Partnerschaftsgesellschaft mbB)

Richter

Französische Kammer — Einzelrichter anonymisiert.

Panel member (anonymized)Presiding judge and judge-rapporteur
Panel member (anonymized)Legally qualified judge
Panel member (anonymized)Technically qualified judge

Patente

EP2196231

CPC-Codes: A61M2209/045, A61M5/148, A61M5/14244

Sektor: Pharmaceutical & Medical

Ausgang

Nur Kosten

Eingereicht: —

Erste Entscheidung: 29. Apr. 2025

Sprache: —

The Central Division Paris issued a costs order in connection with the revocation action UPC_CFI_454/2023, requiring Tandem Diabetes to pay Roche Diabetes Care's representation and litigation costs. The Court rejected Tandem Diabetes's request to stay the costs proceedings pending the appeal against the decision on the merits.